• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

Neutrogena, Johnson & Johnson Shine Light on New Science, Interactive AAD Booth


The company’s combined the need for science advancement with a booth that kept people coming back.

Neutrogena took the 2022 American Academy of Dermatology Annual Meeting by storm recently with its innovative booth design integrating the importance of science, with the fun of photobooths, ring lights, and interactive backgrounds.

Science was a main focus for the company, however, with its parent company Johnson & Johnson announcing the presentation of 11 posters with new research highlighting topics ranging from the effects of oat against environmental and anti-inflammatory triggers, the clinical benefits of vitamin C serums across diverse skin types, among more.

Recent innovations for the company include the Neutrogena Rapid Wrinkle Repair Retinol Pro+ .5% Power serum, according to a press release announcing the poster presentations. This serum contains the brands highest concentration of .5% pure retinol in a skin-nourishing serum. The Neutrogena Stubborn line provides, according to the company, dermatologist-grade over-the-counter options for acne-prone skin or hyperpigmentation. Additionally, Aveeno’s Calm + Restore line helps restore the moisture barrier with prebiotic oat and the Exuviance Age Reverse + Rebuild-5 is formulated with 5 rejuvenating ingredients. These ingredients include mircrodipeptide229, which visibly firms the skin on only 2 weeks, according to the release.

The posters presented at the meeting included:

Poster #33555: “High Concentration (15%) Vitamin C (Ascorbic Acid) Stabilized in Unique Aqueous Vehicle with Feverfew, Polyhydroxy Acid (PHA) and Epigallocatechin Gallate (EGCG) Provides Clinical Benefits for Hyperpigmentation in a Diverse Population.”

Poster #33550: “Topical Oat-Containing Formulations Provide Skin Protection Against Environmental and Inflammatory Triggers for Atopic Dermatitis In Vitro.”

Poster #33131: “Modeling Acute and Cumulative Erythemal Sun Exposure on Vulnerable Body Sites During Beach Vacations Utilizing Behavior Encoded 3D Body Models.”

Poster #33562: “Understanding Mental Stress and Skin Aging Connection Among Dermatologists and Psychologists Through Real-World Evidence.”

Poster #33127: “A Cross-Sectional Examination of Sunburn Incidence in the Context of Race/Ethnicity and Skin Type.”

Poster #33559: “Skin Maturation Processes Observed in Infants Extend Well into the Childhood Period.”

Poster #33565: “Clinically Proven Anti-Aging Effects of a New Skincare Line and Retinol Tolerance Building Guidance for Asian Consumers.”

Poster #33568: “Evaluating the Mildness of Glycinate-based Cleanser Through in Vitro Methodologies and Computational Modeling.”

Poster #33572: “Real-world Evidence (RWE) on Sunscreen Compliance and Photodamage Perception Among Consumers and Dermatologists.”

Poster #33576: “How Lifestyle-Based Environmental Exposures Impact Skin Health through Microbiome.”

Poster #33577: “Novel 10% Multi-Acid Serum Provides Clinical Acne and Complexion Benefits in Subjects with Mild to Moderate Acne.”

“Skin is the body’s first line of defense, and our research over the past year has led to next-generation innovations that showcase new ways to treat and protect it,” said MenasKizoulis, director, scientific engagement, Johnson & Johnson Consumer Health, in the release. “From the treatment of skin conditions such as atopic dermatitis, to evaluating how mental stress impacts skin integrity, to a cutting-edge study using 3D modeling to look at external factors impacting skin, Johnson & Johnson Consumer Health is dedicated to taking an integrated approach to advancing and promoting skin health.”


Johnson & Johnson Consumer Health unveils new skin health research at 2022 American Academy of Dermatology meeting. Associated Press. Press release. Published March 25, 2022. Assessed March 31, 2022. https://apnews.com/press-release/pr-newswire/technology-business-health-lifestyle-johnson-and-johnson-ea9ecf8528b62a37644445839a35a76a 

Recent Videos
© 2024 MJH Life Sciences

All rights reserved.